Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

Presentation TCT 2025

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2024

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Presenter: Jung-Kyu Han

October 27, 2024

Presentation TCT 2023

Minimizing Platelet Reactivity in High-Risk Cases

Presenter: Mitul Patel

October 26, 2023

Presentation TCT 2023

TCT 2: Different Association of Plasma Atherogenicity Assessed by Atherogenic Index of Plasma With the Risk of High Platelet Reactivity According to the Presentation of Acute Myocardial Infarction

Presenter: Ki-Bum Won

October 26, 2023

Presentation TCT 2023

TCT 226: Impact of Platelet Reactivity on Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients according to the Presence or Absence of Chronic Total Occlusion: Analysis from PTRG-DES Registry

Presenter: Donghoon Han

October 24, 2023

Presentation TCT 2022

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

Presenter: Sang Yeub Lee

September 19, 2022

Presentation TCT 2022

TCT 32: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients According to LV Dysfunction Status: Analysis from PTRG-DES(Platelet function and genoType-Related long-term proGnosis in DES-treated patients)…

Presenter: Donghoon Han

September 19, 2022

Presentation TCT 2022

TCT 30: Platelet Reactivity and Clinical Outcomes after Drug-Eluting Stent Implantation in East Asian Patients: Results from the PTRG-DES Consortium

Presenter: Byeong-Keuk Kim

September 19, 2022

Presentation TCT 2022

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Presenter: Donggyu Moon

September 17, 2022

Presentation TCT 2022

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

Presenter: Niels van der Sangen

September 17, 2022

Presentation TCT 2022

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

Presenter: Jeehoon Kang

September 17, 2022

Presentation TCT 2022

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

Presenter: Yoshinobu Onuma

September 17, 2022

Presentation TCT 2022

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

Presenter: Alessandro Spirito

September 17, 2022

Presentation TCT 2022

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Presenter: KI-HYUN JEON

September 17, 2022

Presentation TCT 2022

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 27: Ticagrelor versus Prasugrel in an All-Comer Patient Cohort undergoing Percutaneous Coronary Intervention

Presenter: Anoop Koshy

September 17, 2022

Presentation TCT 2022

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

Presenter: André Luz

September 17, 2022

Presentation TCT 2022

TCT 24: Ticagrelor versus Prasugrel in Acute Myocardial Infarction for East Asians

Presenter: Ji sung KIM

September 17, 2022

Presentation TCT 2022

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial

Presenter: Jeehoon Kang

September 17, 2022

Advertisement

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Minimizing Platelet Reactivity in High-Risk Cases

TCT 2: Different Association of Plasma Atherogenicity Assessed by Atherogenic Index of Plasma With the Risk of High Platelet Reactivity According to the Presentation of Acute Myocardial Infarction

TCT 226: Impact of Platelet Reactivity on Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients according to the Presence or Absence of Chronic Total Occlusion: Analysis from PTRG-DES Registry

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

TCT 32: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients According to LV Dysfunction Status: Analysis from PTRG-DES(Platelet function and genoType-Related long-term proGnosis in DES-treated patients)…

TCT 30: Platelet Reactivity and Clinical Outcomes after Drug-Eluting Stent Implantation in East Asian Patients: Results from the PTRG-DES Consortium

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

TCT 27: Ticagrelor versus Prasugrel in an All-Comer Patient Cohort undergoing Percutaneous Coronary Intervention

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

TCT 24: Ticagrelor versus Prasugrel in Acute Myocardial Infarction for East Asians

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content